Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 12.65

(-1.94%)

Gross Profit Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual gross profit in 2023 was 592 Thousand TWD , down -49.49% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly gross profit in 2024 Q2 was 1.98 Million TWD , up 118.64% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a annual gross profit of 1.17 Million TWD in annual gross profit 2022, down 0.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a annual gross profit of - TWD in annual gross profit 2021, down 0.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly gross profit of 1.98 Million TWD for 2024 Q1, up 571.62% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly gross profit of - TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Gross Profit of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 592 Thousand TWD -49.49%
2022 1.17 Million TWD 0.0%
2021 - TWD 0.0%
2020 - TWD 0.0%
2019 - TWD 0.0%

Peer Gross Profit Comparison of Mercury Biopharmaceutical Corporation

Name Gross Profit Gross Profit Difference
Allied Biotech Corporation 246.43 Million TWD 99.76%
GeneFerm Biotechnology Co., Ltd. 286.35 Million TWD 99.793%
Easywell Biomedicals, Inc. 170.71 Million TWD 99.653%
TTY Biopharm Company Limited 3.22 Billion TWD 99.982%
Synmosa Biopharma Corporation 2.11 Billion TWD 99.972%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 99.972%
Center Laboratories, Inc. 618.09 Million TWD 99.904%
Tien Liang BioTech Co., Ltd. 286.14 Million TWD 99.793%
Orient Pharma Co., Ltd. 468.66 Million TWD 99.874%
InnoPharmax Inc. 17.45 Million TWD 96.609%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 99.758%
Excelsior Biopharma Inc. 306.93 Million TWD 99.807%
DV Biomed Co., Ltd. 764.27 Million TWD 99.923%
Foresee Pharmaceuticals Co., Ltd. 113.97 Million TWD 99.481%
Handa Pharmaceuticals, Inc. 1.1 Billion TWD 99.946%
UniPharma Co., Ltd. 51.01 Million TWD 98.84%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 99.851%
Alar Pharmaceuticals Inc. 465.92 Million TWD 99.873%
Winston Medical Supply Co., Ltd. 347.59 Million TWD 99.83%
Bioray Biotech Co., Ltd 77.65 Million TWD 99.238%
TSH Biopharm Corporation Limited 399.89 Million TWD 99.852%